Drugs / Chylobinoid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06570941 | Mar → Sep 2024 overdue | restless legs syndrome | Synthonics Inc | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chylobinoid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06570941 ↗ |
| Route | Topical | “Participants will be asked to apply the topical cream to the affected area 30 to 45 minutes before bedtime” NCT06570941 ↗ |